Skip to main content
. 2022 Feb 10;10:814194. doi: 10.3389/fped.2022.814194

Figure 5.

Figure 5

Cumulative transfusion-free survival in a cohort of 72 transfused neonates, grouped according to the occurrence of stage 3 or higher retinopathy of prematurity (ROP). (A) Transfusion-free survival estimated according to postnatal day at first RBC transfusion does not significantly differ between patients with and without severe ROP. (B) Transfusion-free survival estimated according to postmenstrual age at first transfusion is significantly lower in neonates developing severe ROP. (C) The difference between groups is even greater if survival to the second RBC transfusion event is considered. RBC, red blood cell.